Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates

Xenetic Biosciences (XBIO) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $0.83 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +29.69%. A quarter ago, it was expected that this company would post a loss of $0.72 per share when it actually produced a loss of $0.59, delivering a surprise of +18.06%. Over the last four quarters, the company ha ...